The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Oral Proteins and Peptides Revenue 1.5 Market Analysis by Type 1.5.1 Global Oral Proteins and Peptides Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Linaclotide 1.5.3 Calcitonin 1.5.4 Insulin 1.5.5 Octreotide 1.6 Market by Application 1.6.1 Global Oral Proteins and Peptides Market Share by Application: 2021-2026 1.6.2 Gastric & Digestive Disorders 1.6.3 Bone Diseases 1.6.4 Diabetes 1.6.5 Hormonal Disorders 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Oral Proteins and Peptides Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Oral Proteins and Peptides Market Players Profiles 3.1 Allergan 3.1.1 Allergan Company Profile 3.1.2 Allergan Oral Proteins and Peptides Product Specification 3.1.3 Allergan Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Sanofi 3.2.1 Sanofi Company Profile 3.2.2 Sanofi Oral Proteins and Peptides Product Specification 3.2.3 Sanofi Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Generex Biotechnology 3.3.1 Generex Biotechnology Company Profile 3.3.2 Generex Biotechnology Oral Proteins and Peptides Product Specification 3.3.3 Generex Biotechnology Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 AstraZeneca 3.4.1 AstraZeneca Company Profile 3.4.2 AstraZeneca Oral Proteins and Peptides Product Specification 3.4.3 AstraZeneca Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Tarsa Therapeutics 3.5.1 Tarsa Therapeutics Company Profile 3.5.2 Tarsa Therapeutics Oral Proteins and Peptides Product Specification 3.5.3 Tarsa Therapeutics Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Biocon 3.6.1 Biocon Company Profile 3.6.2 Biocon Oral Proteins and Peptides Product Specification 3.6.3 Biocon Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Synthetic Biologics 3.7.1 Synthetic Biologics Company Profile 3.7.2 Synthetic Biologics Oral Proteins and Peptides Product Specification 3.7.3 Synthetic Biologics Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Synergy Pharmaceuticals 3.8.1 Synergy Pharmaceuticals Company Profile 3.8.2 Synergy Pharmaceuticals Oral Proteins and Peptides Product Specification 3.8.3 Synergy Pharmaceuticals Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Novo Nordisk 3.9.1 Novo Nordisk Company Profile 3.9.2 Novo Nordisk Oral Proteins and Peptides Product Specification 3.9.3 Novo Nordisk Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 Hoffmann-La Roche 3.10.1 Hoffmann-La Roche Company Profile 3.10.2 Hoffmann-La Roche Oral Proteins and Peptides Product Specification 3.10.3 Hoffmann-La Roche Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 Hovione 3.11.1 Hovione Company Profile 3.11.2 Hovione Oral Proteins and Peptides Product Specification 3.11.3 Hovione Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 Novartis 3.12.1 Novartis Company Profile 3.12.2 Novartis Oral Proteins and Peptides Product Specification 3.12.3 Novartis Oral Proteins and Peptides Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Oral Proteins and Peptides Market Competition by Market Players 4.1 Global Oral Proteins and Peptides Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Oral Proteins and Peptides Revenue Market Share by Market Players (2015-2020) 4.3 Global Oral Proteins and Peptides Average Price by Market Players (2015-2020) 5 Global Oral Proteins and Peptides Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Oral Proteins and Peptides Market Size (2015-2020) 5.1.2 Oral Proteins and Peptides Key Players in North America (2015-2020) 5.1.3 North America Oral Proteins and Peptides Market Size by Type (2015-2020) 5.1.4 North America Oral Proteins and Peptides Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Oral Proteins and Peptides Market Size (2015-2020) 5.2.2 Oral Proteins and Peptides Key Players in East Asia (2015-2020) 5.2.3 East Asia Oral Proteins and Peptides Market Size by Type (2015-2020) 5.2.4 East Asia Oral Proteins and Peptides Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Oral Proteins and Peptides Market Size (2015-2020) 5.3.2 Oral Proteins and Peptides Key Players in Europe (2015-2020) 5.3.3 Europe Oral Proteins and Peptides Market Size by Type (2015-2020) 5.3.4 Europe Oral Proteins and Peptides Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Oral Proteins and Peptides Market Size (2015-2020) 5.4.2 Oral Proteins and Peptides Key Players in South Asia (2015-2020) 5.4.3 South Asia Oral Proteins and Peptides Market Size by Type (2015-2020) 5.4.4 South Asia Oral Proteins and Peptides Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Oral Proteins and Peptides Market Size (2015-2020) 5.5.2 Oral Proteins and Peptides Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Oral Proteins and Peptides Market Size by Type (2015-2020) 5.5.4 Southeast Asia Oral Proteins and Peptides Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Oral Proteins and Peptides Market Size (2015-2020) 5.6.2 Oral Proteins and Peptides Key Players in Middle East (2015-2020) 5.6.3 Middle East Oral Proteins and Peptides Market Size by Type (2015-2020) 5.6.4 Middle East Oral Proteins and Peptides Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Oral Proteins and Peptides Market Size (2015-2020) 5.7.2 Oral Proteins and Peptides Key Players in Africa (2015-2020) 5.7.3 Africa Oral Proteins and Peptides Market Size by Type (2015-2020) 5.7.4 Africa Oral Proteins and Peptides Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Oral Proteins and Peptides Market Size (2015-2020) 5.8.2 Oral Proteins and Peptides Key Players in Oceania (2015-2020) 5.8.3 Oceania Oral Proteins and Peptides Market Size by Type (2015-2020) 5.8.4 Oceania Oral Proteins and Peptides Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Oral Proteins and Peptides Market Size (2015-2020) 5.9.2 Oral Proteins and Peptides Key Players in South America (2015-2020) 5.9.3 South America Oral Proteins and Peptides Market Size by Type (2015-2020) 5.9.4 South America Oral Proteins and Peptides Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Oral Proteins and Peptides Market Size (2015-2020) 5.10.2 Oral Proteins and Peptides Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Oral Proteins and Peptides Market Size by Type (2015-2020) 5.10.4 Rest of the World Oral Proteins and Peptides Market Size by Application (2015-2020) 6 Global Oral Proteins and Peptides Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Oral Proteins and Peptides Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Oral Proteins and Peptides Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Oral Proteins and Peptides Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Oral Proteins and Peptides Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Oral Proteins and Peptides Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Oral Proteins and Peptides Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Oral Proteins and Peptides Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Oral Proteins and Peptides Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Oral Proteins and Peptides Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Oral Proteins and Peptides Consumption by Countries 7 Global Oral Proteins and Peptides Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Oral Proteins and Peptides (2021-2026) 7.2 Global Forecasted Revenue of Oral Proteins and Peptides (2021-2026) 7.3 Global Forecasted Price of Oral Proteins and Peptides (2021-2026) 7.4 Global Forecasted Production of Oral Proteins and Peptides by Region (2021-2026) 7.4.1 North America Oral Proteins and Peptides Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Oral Proteins and Peptides Production, Revenue Forecast (2021-2026) 7.4.3 Europe Oral Proteins and Peptides Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Oral Proteins and Peptides Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Oral Proteins and Peptides Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Oral Proteins and Peptides Production, Revenue Forecast (2021-2026) 7.4.7 Africa Oral Proteins and Peptides Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Oral Proteins and Peptides Production, Revenue Forecast (2021-2026) 7.4.9 South America Oral Proteins and Peptides Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Oral Proteins and Peptides Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Oral Proteins and Peptides by Application (2021-2026) 8 Global Oral Proteins and Peptides Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Oral Proteins and Peptides by Country 8.2 East Asia Market Forecasted Consumption of Oral Proteins and Peptides by Country 8.3 Europe Market Forecasted Consumption of Oral Proteins and Peptides by Countriy 8.4 South Asia Forecasted Consumption of Oral Proteins and Peptides by Country 8.5 Southeast Asia Forecasted Consumption of Oral Proteins and Peptides by Country 8.6 Middle East Forecasted Consumption of Oral Proteins and Peptides by Country 8.7 Africa Forecasted Consumption of Oral Proteins and Peptides by Country 8.8 Oceania Forecasted Consumption of Oral Proteins and Peptides by Country 8.9 South America Forecasted Consumption of Oral Proteins and Peptides by Country 8.10 Rest of the world Forecasted Consumption of Oral Proteins and Peptides by Country 9 Global Oral Proteins and Peptides Sales by Type (2015-2026) 9.1 Global Oral Proteins and Peptides Historic Market Size by Type (2015-2020) 9.2 Global Oral Proteins and Peptides Forecasted Market Size by Type (2021-2026) 10 Global Oral Proteins and Peptides Consumption by Application (2015-2026) 10.1 Global Oral Proteins and Peptides Historic Market Size by Application (2015-2020) 10.2 Global Oral Proteins and Peptides Forecasted Market Size by Application (2021-2026) 11 Global Oral Proteins and Peptides Manufacturing Cost Analysis 11.1 Oral Proteins and Peptides Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Oral Proteins and Peptides 12 Global Oral Proteins and Peptides Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Oral Proteins and Peptides Distributors List 12.3 Oral Proteins and Peptides Customers 12.4 Oral Proteins and Peptides Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 2,400 | Date : Jan 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 133 |
Price : US$ 2,400 | Date : Jan 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 133 |
Price : US$ 2,400 | Date : Jan 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 126 |
Price : US$ 3,000 | Date : Jan 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 189 |
Price : US$ 4,950 | Date : Jan 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 140 |
We will be happy to help you find what you need. Please call us or write to us: